表紙
市場調查報告書

核酸分離、精製的全球市場:產品 (套件、試劑、設備),手法(管柱、磁性珠),類型 (基因DNA、質體DNA、miRNA),用途 (藥物研發、精密醫療) - 2025年為止的預測

Nucleic Acid Isolation & Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Precision Medicine), End User (Academic)-Global Forecast to 2025

出版商 MarketsandMarkets 商品編碼 941357
出版日期 內容資訊 英文 192 Pages
訂單完成後即時交付
價格
核酸分離、精製的全球市場:產品 (套件、試劑、設備),手法(管柱、磁性珠),類型 (基因DNA、質體DNA、miRNA),用途 (藥物研發、精密醫療) - 2025年為止的預測 Nucleic Acid Isolation & Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Precision Medicine), End User (Academic)-Global Forecast to 2025
出版日期: 2020年06月03日內容資訊: 英文 192 Pages
簡介

全球核酸分離、精製市場規模預測將從2020年的32億美元,到2025年達到48億美元,在預測期間內的年複合成長率預測將為8.9%。促進該市場的成長的主要原因,是R&D活動的增加,技術進步,及自動化的擴大。可是,自動化設備的高成本,預計妨礙市場成長。

本報告提供全球核酸分離、精製市場相關調查,市場概要,各產品、手法、類型、用途、終端用戶,及各地區的市場分析與預測,競爭情形分析,及主要企業簡介等資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 核酸分離、精製市場概要
  • 北美的核酸分離、精製市場:各產品
  • 核酸分離、精製市場地區概述

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 趨勢

第6章 核酸分離、精製市場:各產品

  • 簡介
  • 套件
  • 試劑
  • 設備

第7章 核酸分離、精製市場:各手法

  • 簡介
  • 管柱為基礎
  • 磁微珠為基礎
  • 試劑為基礎
  • 其他

第8章 核酸分離、精製市場:各類型

  • 簡介
  • 質體DNA核酸分離、精製
  • 總數RNA核酸分離、精製
  • 基因DNA核酸分離、精製
  • mRNA核酸分離、精製
  • 循環核酸分離、精製
  • 微型核糖核酸核酸分離、精製
  • PCR收拾乾淨
  • 其他

第9章 核酸分離、精製市場:各用途

  • 簡介
  • 診斷
  • 藥物研發、開發
  • 個人化醫療
  • 農業、動物研究
  • 其他的用途

第10章 核酸分離、精製市場:各終端用戶

  • 簡介
  • 醫院、診斷中心
  • 學術、政府研究機關
  • 醫藥品、生物科技企業
  • CRO
  • 其他終端用戶

第11章 核酸分離、精製市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他的歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他的亞太地區
  • 其他地區
    • 南美
    • 中東、非洲

第12章 競爭情形

  • 簡介
  • 市場評估組成架構
  • 主要的市場參與企業的收益分析
  • 競爭模式

第13章 企業評估矩陣、企業簡介

  • 公司評估矩陣
  • 競爭領導製圖

第14章 企業簡介

  • QIAGEN N.V.
  • THERMO FISHER SCIENTIFIC
  • F. HOFFMAN-LA ROCHE AG
  • PROMEGA CORPORATION
  • AGILENT TECHNOLOGIES
  • BIO-RAD LABORATORIES
  • DANAHER CORPORATION
  • GE HEALTHCARE
  • ILLUMINA
  • MERCK KGAA
  • TaKaRa BIO
  • NEW ENGLAND BIOLABS
  • ZYMO RESEARCH
  • NORGEN BIOTEK
  • OMEGA BIO-TEK, INC.
  • 其他公司
    • GENAXXON BIOSCIENCE GMBH
    • 3B BLACKBIO BIOTECH INDIA LTD。
    • INVITEK MOLECULAR GMBH
    • BIOVISION
    • ANALYTIK JENA AG

第15章 附錄

目錄
Product Code: BT 2398

"The nucleic acid isolation and purification market is projected to grow at a CAGR of 8.9% during the forecast period (2020-2025)."

The global nucleic acid isolation and purification market is projected to reach USD 4.8 billion by 2025 from USD 3.2 billion in 2020, at a CAGR of 8.9% during the forecast period. The major factors driving the growth of the market include increasing R&D activities as well as technological advancements and increasing automation. However, the high cost of automated instruments is expected to hinder the growth of the market.

"The instruments segment will grow at the highest rate during the forecast period."

On the basis of product, the nucleic acid isolation and purification market is segmented into kits, reagents, and instruments. In 2019, kits were the largest product segment in the market. Growth in this market can be attributed to the continuous focus of key market players on developing and launching new and advanced kits. However, the instruments segment is expected to grow at the highest rate during the forecast period.

"By type, the plasmid DNA isolation and purification segment accounted for the largest share of the nucleic acid isolation and purification market in 2019."

On the basis of type, the global nucleic acid isolation and purification market is segmented into plasmid DNA isolation and purification, total RNA isolation and purification, circulating nucleic acid isolation and purification, genomic DNA isolation and purification, messenger RNA isolation and purification, microRNA isolation and purification, PCR cleanup, and other nucleic acid isolation and purification types. The plasmid DNA isolation segment accounted for the largest share of the nucleic acid isolation and purification market in 2019. The large share of this market segment can be attributed to the wide use of purified plasmid DNA in a variety of downstream applications, such as PCR, sequencing, expression of proteins, gene therapy, and transfection.

"The market in the Asia Pacific is projected to witness the highest growth rate during the forecast period (2020-2025)."

North America accounted for the largest share of the nucleic acid isolation and purification market in 2019. Significant R&D spending in biotechnology and pharmaceutical companies, the large size of the biotechnology industry, technological advancements, and government support in the region are the key factors driving the growth of the nucleic acid isolation and purification market in North America. On the other hand, the Asia Pacific is projected to register the highest growth during the forecast period. This large share can be attributed to factors such as the increasing number of genomic projects and increasing R&D investments by pharmaceutical & biotechnology companies in this region.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type (Supply-side): Tier 1 (29%), Tier 2 (37%), and Tier 3 (34%)
  • By Category (Demand-side): Pharmaceutical & Biotechnology Companies (38%), Hospitals & Diagnostic Centers (30%), and Academic & Government Research Institutes (22%), and Other End Users (10%)
  • By Designation: C-level (37%), Director-level (23%), and Managers (40%)
  • By Region: North America (37%), Europe (30%), Asia Pacific (21%), and the RoW (12%)

QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (US), and F. Hoffmann-La Roche Ltd. (Switzerland) are the leading players in the global nucleic acid isolation and purification market. Other notable players in this market include Promega Corporation (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Danaher Corporation (US), GE Healthcare (US), Illumina, Inc. (US), Merck KGaA (Germany), Takara Bio (Japan), Zymo Research (US), New England Biolabs (US), Norgen Biotek Corp (Canada), Omega Bio-tek (US), Genaxxon Bioscience GmbH (Germany), 3B BlackBio Biotech India Limited (India), Invitek Molecular (Germany), BioVision (US), and Analytik Jena AG (Germany).

Research Coverage:

The report analyzes the nucleic acid isolation and purification market and aims at estimating the market size and future growth potential of this market based on various segments such as product, method, type, application, end user, and region. The report also includes the competitive analysis of the key players in this market, along with their company profiles, product & service offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the nucleic acid isolation and purification market. The report analyzes the market based on the product, type, application, end user, and region.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the nucleic acid isolation and purification market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of nucleic acid isolation and purification solutions across regions.
  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the nucleic acid isolation and purification market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the nucleic acid isolation and purification market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Breakdown of primary sources
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET GROWTH RATE PROJECTIONS
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5 MARKET SHARE ESTIMATION
  • 2.6 ASSUMPTIONS FOR THE STUDY
  • 2.7 LIMITATIONS FOR RESEARCH

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET OVERVIEW
  • 4.2 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT (2019)
  • 4.3 GEOGRAPHICAL SNAPSHOT OF THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET

5 MARKET OVERVIEW

  • 5.1 MARKET DYNAMICS
    • 5.1.1 DRIVERS
      • 5.1.1.1 Increasing R&D activities
      • 5.1.1.2 Technological advancements and increasing automation
    • 5.1.2 RESTRAINTS
      • 5.1.2.1 High cost of automated instruments
    • 5.1.3 OPPORTUNITIES
      • 5.1.3.1 High scope of growth in emerging economies
      • 5.1.3.2 Improving regulatory and reimbursement scenario
      • 5.1.3.3 Molecular diagnostics and personalized medicine
    • 5.1.4 TRENDS
      • 5.1.4.1 Impact of the COVID-19 pandemic
      • 5.1.4.2 Increase in government funding

6 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 KITS
    • 6.2.1 KITS WERE THE LARGEST PRODUCT SEGMENT IN THE MARKET IN 2019
  • 6.3 REAGENTS
    • 6.3.1 REAGENTS SEGMENT TO GROW AT A STEADY RATE DURING THE FORECAST PERIOD
  • 6.4 INSTRUMENTS
    • 6.4.1 AUTOMATED INSTRUMENTS ENABLE A FASTER, CLEANER, AND MORE CONSISTENT NUCLEIC ACID EXTRACTION PROCESS

7 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD

  • 7.1 INTRODUCTION
  • 7.2 COLUMN-BASED ISOLATION AND PURIFICATION
    • 7.2.1 COLUMN-BASED ISOLATION AND PURIFICATION WAS THE LARGEST SEGMENT IN THE MARKET IN 2019
  • 7.3 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION
    • 7.3.1 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • 7.4 REAGENT-BASED ISOLATION AND PURIFICATION
    • 7.4.1 REAGENT-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER STEADY GROWTH DURING THE FORECAST PERIOD
  • 7.5 OTHER ISOLATION AND PURIFICATION METHODS

8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE

  • 8.1 INTRODUCTION
  • 8.2 PLASMID DNA ISOLATION AND PURIFICATION
    • 8.2.1 PLASMID DNA ISOLATION AND PURIFICATION ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET
  • 8.3 TOTAL RNA ISOLATION AND PURIFICATION
    • 8.3.1 TOTAL RNA ISOLATION AND PURIFICATION SEGMENT TO REGISTER STEADY GROWTH
  • 8.4 GENOMIC DNA ISOLATION AND PURIFICATION
    • 8.4.1 GENOMIC DNA ISOLATION IS THE FIRST STEP IN GENETIC-BASED TESTS
  • 8.5 MESSENGER RNA ISOLATION AND PURIFICATION
    • 8.5.1 MESSENGER RNA ISOLATION AND PURIFICATION IS MAINLY USED IN THE STUDY OF GENE EXPRESSION AND TRANSCRIPTOMICS
  • 8.6 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION
    • 8.6.1 CLINICAL APPLICATIONS TO DRIVE THE MARKET FOR CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION
  • 8.7 MICRORNA ISOLATION AND PURIFICATION
    • 8.7.1 MICRORNA KITS PROVIDE RAPID ISOLATION AND PURIFICATION OF RNA MOLECULES FROM SAMPLES
  • 8.8 PCR CLEANUP
    • 8.8.1 TIME-CONSUMING LABORATORY PROCEDURES TO LIMIT THE GROWTH OF THIS MARKET DURING THE FORECAST PERIOD
  • 8.9 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES

9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
  • 9.2 DIAGNOSTICS
    • 9.2.1 DIAGNOSTIC APPLICATIONS FORM THE LARGEST AND FASTEST-GROWING SEGMENT IN THE MARKET
  • 9.3 DRUG DISCOVERY & DEVELOPMENT
    • 9.3.1 NGS BENEFITS DRUG DISCOVERY APPLICATIONS IN VARIOUS THERAPEUTIC AREAS
  • 9.4 PERSONALIZED MEDICINE
    • 9.4.1 RISING INCIDENCE OF CANCER AND INCREASING RESEARCH AND FUNDING TO DRIVE THE MARKET FOR THIS SEGMENT
  • 9.5 AGRICULTURE & ANIMAL RESEARCH
    • 9.5.1 FAVORABLE FUNDING SCENARIO TO SUPPORT MARKET GROWTH
  • 9.6 OTHER APPLICATIONS

10 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 HOSPITALS & DIAGNOSTIC CENTERS
    • 10.2.1 AVAILABILITY OF GENETIC TESTS AND RISING FOCUS ON PERSONALIZED MEDICINE IN HOSPITALS TO DRIVE MARKET GROWTH
  • 10.3 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
    • 10.3.1 INCREASE IN RESEARCH INTENSITY TO DRIVE THE USAGE OF NUCLEIC ACID ISOLATION AND PURIFICATION SYSTEMS
  • 10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 10.4.1 INCREASING NUMBER OF RESEARCH PROJECTS IN GENOMICS AND RELATED AREAS IS EXPECTED TO DRIVE THE MARKET
  • 10.5 CONTRACT RESEARCH ORGANIZATIONS
    • 10.5.1 CONTRACT RESEARCH ORGANIZATIONS ARE EXPECTED TO REGISTER STEADY GROWTH DURING THE FORECAST PERIOD
  • 10.6 OTHER END USERS

11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 US
      • 11.2.1.1 Government and private funding to support market growth in the US
    • 11.2.2 CANADA
      • 11.2.2.1 Demand for nucleic acid isolation and purification in Canada is increasing primarily due to growing investments in genomics
  • 11.3 EUROPE
    • 11.3.1 GERMANY
      • 11.3.1.1 Germany is the largest market for nucleic acid isolation and purification in Europe
    • 11.3.2 UK
      • 11.3.2.1 Government support for research in the form of investments, funds, and grants to support market growth
    • 11.3.3 FRANCE
      • 11.3.3.1 High cancer burden in France to drive market growth
    • 11.3.4 ROE
  • 11.4 ASIA PACIFIC
    • 11.4.1 CHINA
      • 11.4.1.1 China to register the highest growth in the nucleic acid isolation and purification market in APAC
    • 11.4.2 JAPAN
      • 11.4.2.1 Japan to register steady growth during the forecast period
    • 11.4.3 INDIA
      • 11.4.3.1 Strong growth trends in the pharmaceutical & biotechnology industries to drive the market in India
    • 11.4.4 ROAPAC
  • 11.5 REST OF THE WORLD
    • 11.5.1 LATIN AMERICA
      • 11.5.1.1 To prevent cancer mortality, the Brazilian government recommends screening programs for breast and prostate cancer
    • 11.5.2 MIDDLE EAST & AFRICA
      • 11.5.2.1 Lack of infrastructure for research to hamper the growth of the NAIP market in the Middle East & Africa

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 MARKET EVALUATION FRAMEWORK
  • 12.3 REVENUE ANALYSIS OF TOP MARKET PLAYERS
  • 12.4 COMPETITIVE SCENARIO
    • 12.4.1 COLLABORATIONS & AGREEMENTS
    • 12.4.2 PRODUCT LAUNCHES & APPROVALS
    • 12.4.3 ACQUISITIONS
    • 12.4.4 EXPANSIONS

13 COMPANY EVALUATION MATRIX AND COMPANY PROFILES

  • 13.1 COMPANY EVALUATION MATRIX
    • 13.1.1 MARKET SHARE ANALYSIS
  • 13.2 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET) (2019)
    • 13.2.1 STARS
    • 13.2.2 EMERGING LEADERS
    • 13.2.3 PERVASIVE PLAYERS
    • 13.2.4 EMERGING COMPANIES

14 COMPANY PROFILES (Business Overview, Products Offered, Recent Developments, MnM View)*

  • 14.1 QIAGEN N.V.
  • 14.2 THERMO FISHER SCIENTIFIC
  • 14.3 F. HOFFMAN-LA ROCHE AG
  • 14.4 PROMEGA CORPORATION
  • 14.5 AGILENT TECHNOLOGIES
  • 14.6 BIO-RAD LABORATORIES
  • 14.7 DANAHER CORPORATION
  • 14.8 GE HEALTHCARE
  • 14.9 ILLUMINA
  • 14.10 MERCK KGAA
  • 14.11 TAKARA BIO, INC.
  • 14.12 NEW ENGLAND BIOLABS
  • 14.13 ZYMO RESEARCH
  • 14.14 NORGEN BIOTEK
  • 14.15 OMEGA BIO-TEK, INC.
  • 14.16 OTHER COMPANIES
    • 14.16.1 GENAXXON BIOSCIENCE GMBH
    • 14.16.2 3B BLACKBIO BIOTECH INDIA LTD.
    • 14.16.3 INVITEK MOLECULAR GMBH
    • 14.16.4 BIOVISION
    • 14.16.5 ANALYTIK JENA AG

Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3 AVAILABLE CUSTOMIZATIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 2 NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 3 NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 4 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 5 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 6 COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 7 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 8 REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 9 OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 10 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 11 PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 12 TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 13 GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 14 MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 15 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 16 MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 17 PCR CLEANUP MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 18 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 19 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 20 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 21 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 22 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 23 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 24 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 25 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 26 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 27 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 28 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 29 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 30 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 31 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 32 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 33 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 34 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 35 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 36 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 37 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 38 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 39 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 40 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 41 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 42 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 43 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 44 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 45 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 46 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 47 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 48 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 49 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 50 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 51 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 52 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 53 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 54 CANCER INCIDENCE IN GERMANY, BY TYPE, 2018 VS. 2025
  • TABLE 55 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 56 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 57 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 58 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 59 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 60 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 61 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 62 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 63 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 64 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 65 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 66 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 67 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 68 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 69 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 70 ROE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 71 ROE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 72 ROE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 73 ROE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 74 ROE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 75 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 76 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 77 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 79 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 80 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 81 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 82 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 83 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 84 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 85 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 86 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 87 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 88 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 89 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 90 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 91 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 92 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 93 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 94 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 95 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 96 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 97 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 98 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 99 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 100 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 101 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 102 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 103 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 104 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 105 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 106 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 107 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 108 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 109 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 110 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 111 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 112 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 113 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 114 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 115 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 116 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 PRIMARY SOURCES
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC
  • FIGURE 6 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET - CAGR PROJECTION
  • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • FIGURE 8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
  • FIGURE 9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020 VS. 2025 (USD MILLION)
  • FIGURE 10 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
  • FIGURE 11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
  • FIGURE 12 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
  • FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
  • FIGURE 14 TECHNOLOGICAL ADVANCEMENTS AND INCREASING AUTOMATION TO DRIVE MARKET GROWTH
  • FIGURE 15 KITS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS MARKET IN 2019
  • FIGURE 16 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE IN THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FROM 2020 TO 2025
  • FIGURE 17 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
  • FIGURE 18 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION
  • FIGURE 19 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT
  • FIGURE 20 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT
  • FIGURE 21 MARKET EVOLUTION FRAMEWORK (2017-2019)
  • FIGURE 22 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET IN 2019
  • FIGURE 23 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
  • FIGURE 24 COMPETITIVE LEADERSHIP MAPPING (GLOBAL) NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, 2019
  • FIGURE 25 COMPANY SNAPSHOT: QIAGEN N.V. (2019)
  • FIGURE 26 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC (2019)
  • FIGURE 27 COMPANY SNAPSHOT: F. HOFFMANN-LA ROCHE AG (2019)
  • FIGURE 28 COMPANY SNAPSHOT: AGILENT TECHNOLOGIES INC. (2019)
  • FIGURE 29 COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC. (2019)
  • FIGURE 30 COMPANY SNAPSHOT: DANAHER CORPORATION (2019)
  • FIGURE 31 COMPANY SNAPSHOT: GE HEALTHCARE (2019)
  • FIGURE 32 COMPANY SNAPSHOT: ILLUMINA, INC. (2019)
  • FIGURE 33 COMPANY SNAPSHOT: MERCK KGAA (2019)
  • FIGURE 34 COMPANY SNAPSHOT: TAKARA BIO (2019)